Table 1.
Selected patient baseline characteristics.
| All | Groups | p-Value | ||
|---|---|---|---|---|
| Teledermatology (n = 225) |
Face-to-Face Dermatology (n = 225) |
|||
| Age M(SD) | 52.16 (19.97) | 52.53 (18.17) | 51.78 (21.65) | 0.744 a |
| Women n (%) | 240 (53.3%) | 131 (58.2%) | 109 (48.4%) | 0.047 b |
| EQ-5D utilities (mean) [95 CI] |
0.83 [0.81–0.85] |
0.89 [0.87–0.91] |
0.77 [0.74–0.81] |
0.000 b |
| EQ-5D VAS (mean) [95 CI] |
72.23 [70.06–74.40] |
76.22 [73.29–79.15] |
68.24 [65.10–71.38] |
0.000 b |
| Race/ethnicity n (%) | ||||
| White/Caucasian | 415 (92.22%) | 208 (94.4%) | 207 (92%) | 0.453 b |
| Gypsy | 6 (1.33%) | 4 (1.78%) | 2 (0.89%) | |
| Hispanic/Latino | 10 (2.22%) | 5 (2.22%) | 5 (2.22%) | |
| Black | 3 (0.67%) | 0 (0%) | 3 (1.33%) | |
| Arab | 16 (3.56%) | 8 (3.56%) | 8 (3.56%) | |
| Reason for consultation n (%) | ||||
| Injury | 232 (51.56%) | 140 (62.22%) | 92 (40.89%) | 0.000 b |
| Rash | 52 (11.56%) | 24 (10.67%) | 28 (12.44%) | |
| Injury and rash | 14 (3.11%) | 8 (%) | 6 (2.67%) | |
| Other | 152 (33.78%) | 53 (23.56%) | 99 (44%) | |
| Diagnostic tests performed n (%) | ||||
| None | 363 (80.67%) | 211 (93.78%) | 152 (67.56%) | 0.000 b |
| Blood test | 31 (6.89%) | 7 (3.11%) | 24 (10.67%) | |
| Biopsy | 52 (11.56%) | 6 (2.67%) | 46 (20.44%) | |
| Micro punctures | 3 (0.67%) | 1 (0.44%) | 2 (0.89%) | |
| Anatomical location of the skin problem n (%) | ||||
| Trunk | 83 (18.5%) | 41 (18.2%) | 42 (18.8%) | 0.336 b |
| Limbs | 93 (20.7%) | 42 (18.7%) | 51 (22.8%) | |
| Head and neck | 210 (46.8%) | 113 (50.2%) | 97 (43.3%) | |
| Limbs. head and neck | 13 (2.9%) | 6 (2.7%) | 7 (3.1%) | |
| Trunk and limbs | 24 (5.3%) | 14 (6.2%) | 10 (4.5%) | |
| Whole body | 10 (2.2%) | 5 (2.2%) | 5 (2.2%) | |
| Trunk. head and neck | 16 (3.6%) | 4 (1.8%) | 12 (5.4%) | |
| Treatment n (%) | ||||
| Pharmacological | 246 (54.7%) | 146 (64.9%) | 100 (44.4%) | 0.000 b |
| Surgical | 123 (27.3%) | 31 (13.8%) | 92 (40.9%) | |
| Follow-up and evolution | 55 (12.2%) | 45 (20%) | 10 (4.4%) | |
| Pharmacological. surgical and follow-up | 26 (5.8%) | 3 (1.3%) | 23 (10.2%) | |
| Number of Primary Care visits M(SD) | 1.96 (0.76) | 2.24 (0.65) | 1.68 (0.76) | 0.000 a |
| Number of hospital visits M(SD) | 0.75 (0.95) | 0.01 (0.09) | 1.48 (0.85) | 0.000 a |
a t-Student test; b Chi Squared test.